Disclosure Of Fair Value Measurement [Text Block]

OSE Immunotherapeutics - Filing #831399

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
82 054 EUR
91 781 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
76 643 EUR
4 330 EUR
309,000 EUR
22 975 EUR
408,000 EUR
57 282 EUR
32 658 EUR
65 611 EUR
549,000 EUR
3 705 EUR
220,000 EUR
35 890 EUR
160,000 EUR
47 890 EUR
21 111 EUR
65 605 EUR
150,000 EUR
3 705 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.